Inflammation, demyelination, and degeneration - recent insights from MS pathology.

[1]  H. Lassmann.  Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models , 2010, Experimental Neurology.

[2]  P. Stys,et al.  Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. , 2010, Trends in molecular medicine.

[3]  C. Polman,et al.  Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis , 2010, Multiple sclerosis.

[4]  J A Frank,et al.  Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis , 2010, Multiple sclerosis.

[5]  S. Tiwari-Woodruff,et al.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE , 2010, Laboratory Investigation.

[6]  B. Scheithauer,et al.  Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. , 2010, Brain : a journal of neurology.

[7]  V. Steen,et al.  Upregulation of Immunoglobulin‐related Genes in Cortical Sections from Multiple Sclerosis Patients , 2009, Brain pathology.

[8]  H. Wiendl,et al.  Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte‐directed CD8+ T cell attack , 2009, Glia.

[9]  S. Cepok,et al.  Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease , 2009, Annals of neurology.

[10]  J. Parratt,et al.  Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.

[11]  W. Brück,et al.  Substantial early, but nonprogressive neuronal loss in multiple sclerosis (ms) spinal cord , 2009, Annals of neurology.

[12]  B. Hemmer,et al.  Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica , 2009, Annals of neurology.

[13]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[14]  M. Esiri,et al.  Spinal Cord Neuronal Pathology in Multiple Sclerosis , 2009, Brain pathology.

[15]  H. Lassmann,et al.  Progressive multiple sclerosis , 2009, Seminars in Immunopathology.

[16]  Frauke Zipp,et al.  Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis , 2009, Annals of neurology.

[17]  J. Geurts,et al.  Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis , 2009, Journal of neuropathology and experimental neurology.

[18]  C. Wegner,et al.  Gray matter pathology and multiple sclerosis , 2009, Current neurology and neuroscience reports.

[19]  W. Brück,et al.  Remyelination capacity of the MS brain decreases with disease chronicity , 2009, Neurology.

[20]  J. Pollard,et al.  MS: is it one disease? , 2009, International MS journal.

[21]  H. Lassmann,et al.  Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals , 2009, Proceedings of the National Academy of Sciences.

[22]  F. Barkhof,et al.  Accumulation of cortical lesions in MS: relation with cognitive impairment , 2009, Multiple sclerosis.

[23]  Aristide Merola,et al.  Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter , 2009, Journal of neuropathology and experimental neurology.

[24]  P. Hanson,et al.  Edinburgh Research Explorer Mitochondrial Changes within Axons in Multiple Sclerosis Mitochondrial Changes within Axons in Multiple Sclerosis , 2022 .

[25]  Richard Nicholas,et al.  Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis , 2009, Brain pathology.

[26]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[27]  R. Chawla,et al.  Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase , 2009, Molecular and Cellular Biochemistry.

[28]  H. Savolainen.  CORTICAL DEMYELINATION IN PML AND MS: SIMILARITIES AND DIFFERENCES , 2009, Neurology.

[29]  E. Portaccio,et al.  Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study , 2009, Multiple sclerosis.

[30]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[31]  A. Testori,et al.  Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study , 2009, The Lancet Neurology.

[32]  Joaquín Goñi,et al.  Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. , 2009, Archives of neurology.

[33]  Guillermo Izquierdo,et al.  Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis , 2008, Proceedings of the National Academy of Sciences.

[34]  H. Wekerle.  Lessons from multiple sclerosis: models, concepts, observations , 2008, Annals of the rheumatic diseases.

[35]  H. Hartung,et al.  Persistence of immunopathological and radiological traits in multiple sclerosis. , 2008, Archives of neurology.

[36]  K. Selmaj,et al.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. , 2008, The New England journal of medicine.

[37]  C. Wegner,et al.  Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. , 2008, Brain : a journal of neurology.

[38]  S. Chandran,et al.  Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. , 2008, Brain : a journal of neurology.

[39]  Klaus-Armin Nave,et al.  Axon-glial signaling and the glial support of axon function. , 2008, Annual review of neuroscience.

[40]  Yulin Ge,et al.  Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. , 2008, Archives of neurology.

[41]  W. Brück,et al.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis , 2008, Brain : a journal of neurology.

[42]  B. Kálmán,et al.  Autoantibodies and neurodegeneration in multiple sclerosis , 2008, Laboratory Investigation.

[43]  Hans Lassmann,et al.  Multiple sclerosis and Alzheimer's disease , 2008, Annals of neurology.

[44]  M. Calabrese,et al.  Extensive cortical inflammation is associated with epilepsy in multiple sclerosis , 2008, Journal of Neurology.

[45]  L. Bö,et al.  Homogeneity of active demyelinating lesions in established multiple sclerosis , 2008, Annals of neurology.

[46]  C. Lucchinetti.  Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance , 2007 .

[47]  H. Wiendl,et al.  Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice , 2007, Molecular and Cellular Neuroscience.

[48]  T. Olsson,et al.  Neurofascin as a novel target for autoantibody-mediated axonal injury , 2007, The Journal of experimental medicine.

[49]  R. Rudick,et al.  Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. , 2007, Brain : a journal of neurology.

[50]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[51]  A. Mildner,et al.  Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes , 2007, Nature Genetics.

[52]  R. Mutani,et al.  Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage , 2007, Journal of neuropathology and experimental neurology.

[53]  Bruce D. Trapp,et al.  Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.

[54]  H. Lassmann.  New concepts on progressive multiple sclerosis , 2007, Current neurology and neuroscience reports.

[55]  H. Atkins,et al.  Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. , 2007, Brain : a journal of neurology.

[56]  J. Parisi,et al.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.

[57]  Christine Stadelmann,et al.  Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis , 2007, Brain pathology.

[58]  H. D. de Vries,et al.  The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions , 2007, Journal of neuropathology and experimental neurology.

[59]  B. '. ’t Hart,et al.  Immunization With Neurofilament Light Protein Induces Spastic Paresis and Axonal Degeneration in Biozzi ABH Mice , 2007, Journal of neuropathology and experimental neurology.

[60]  S. McQuaid,et al.  Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis , 2007, Neuropathology and applied neurobiology.

[61]  A. Bar-Or,et al.  Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein , 2007, Nature Medicine.

[62]  Jingwu Z. Zhang.  Immune regulation and immunotherapy in autoimmune disease , 2007 .

[63]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[64]  H. Lassmann,et al.  Cortical Demyelination Can Be Modeled in Specific Rat Models of Autoimmune Encephalomyelitis and Is Major Histocompatability Complex (MHC) Haplotype-Related , 2006, Journal of neuropathology and experimental neurology.

[65]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[66]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[67]  K. Nave,et al.  Immune Cells Contribute to Myelin Degeneration and Axonopathic Changes in Mice Overexpressing Proteolipid Protein in Oligodendrocytes , 2006, The Journal of Neuroscience.

[68]  W. Brück,et al.  Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions , 2006, Multiple sclerosis.

[69]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[70]  W. Brück,et al.  A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. , 2006, Brain : a journal of neurology.

[71]  M. Barnett,et al.  The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion , 2006, Multiple sclerosis.

[72]  D J Mikulis,et al.  Somatosensory cortical atrophy after spinal cord injury: A voxel-based morphometry study , 2006, Neurology.

[73]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[74]  R. Rudick,et al.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.

[75]  Douglas L. Arnold,et al.  Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter , 2006, NeuroImage.

[76]  B. Erickson,et al.  Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology , 2006, Neuroradiology.

[77]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[78]  B. Scheithauer,et al.  Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[79]  P. Matthews,et al.  Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. , 2005, Brain : a journal of neurology.

[80]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[81]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[82]  B. Weinshenker,et al.  Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange , 2005, The Lancet.

[83]  D. Pleasure,et al.  Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. , 2005, Brain : a journal of neurology.

[84]  Hans Lassmann,et al.  Cortical lesions and brain atrophy in MS , 2005, Journal of the Neurological Sciences.

[85]  L. Bö,et al.  The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.

[86]  E. Mandelkow,et al.  Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis* , 2004, Journal of Biological Chemistry.

[87]  M. Schwab,et al.  Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis , 2004, The Journal of experimental medicine.

[88]  M. Esiri,et al.  Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. , 2004, Brain : a journal of neurology.

[89]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[90]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[91]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[92]  K. Rammohan.  Axonal injury in multiple sclerosis , 2003, Current neurology and neuroscience reports.

[93]  P. Adeleine,et al.  Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.

[94]  Kenneth J. Smith,et al.  Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration , 2003, Annals of neurology.

[95]  I. Cohen,et al.  Autoimmune Encephalomyelitis and Uveitis Induced by T Cell Immunity to Self β-Synuclein1 , 2003, The Journal of Immunology.

[96]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[97]  Wolfgang Brück,et al.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.

[98]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[99]  G. Wolswijk,et al.  Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. , 2002, Brain : a journal of neurology.

[100]  E. Cho,et al.  Immunopathology of secondary‐progressive multiple sclerosis , 2001, Annals of neurology.

[101]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[102]  P M Matthews,et al.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.

[103]  G J Barker,et al.  The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.

[104]  P. Matthews,et al.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.

[105]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[106]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[107]  M. Palkovits,et al.  Axonal changes in chronic demyelinated cervical spinal cord plaques. , 2000, Brain : a journal of neurology.

[108]  L. Turski,et al.  Autoimmune encephalomyelitis ameliorated by AMPA antagonists , 2000, Nature Medicine.

[109]  A. Thompson,et al.  The effect of interferon beta-1 b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis , 2000 .

[110]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[111]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[112]  R. Herndon,et al.  A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.

[113]  C. Granger,et al.  Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. , 1999, Journal of neuroimmunology.

[114]  W. Brück,et al.  Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions , 1998, Multiple sclerosis.

[115]  J. Merrill,et al.  The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.

[116]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[117]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[118]  K. Jellinger,et al.  Patterns of oligodendroglia pathology in multiple sclerosis. , 1994, Brain : a journal of neurology.

[119]  D. Graham,et al.  β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury , 1993, Neuroscience Letters.

[120]  E. Cho,et al.  Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .

[121]  E. Cho,et al.  Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.

[122]  W. Owens.  Clinical course. , 1955, American journal of ophthalmology.

[123]  J. Cavanagh,et al.  Demyelination , 2020, British medical bulletin.